Related Experiment Video
Updated: Aug 19, 2025

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
Marjolin's Ulcer After Saphenectomy: A Case Report
Carlos E Rodriguez1, Diego F Cardona1, Theresa W Rodriguez2
1General Surgery, Instituto de Pós Graduação Médica Carlos Chagas, Rio de Janeiro, BRA.
Marjolin's ulcer, a rare squamous cell carcinoma, can arise from chronic wounds like burn scars. Early treatment of ulcerative lesions is crucial for preventing this malignancy.
Area of Science:
- Dermatology
- Oncology
- Surgical Pathology
Background:
- Chronic wounds, particularly burn scars, carry a risk of malignant transformation.
- Squamous cell carcinoma is the most common malignancy arising in chronic wounds, termed Marjolin's ulcer.
- Marjolin's ulcer is a rare clinical entity with no definitive treatment protocol.
Observation:
- This case report details a rare Marjolin's ulcer in a 50-year-old male with a history of saphenectomy on the left leg.
- The patient underwent surgical excision and rotation flap reconstruction for the ulcer.
- The patient's ulcer developed on the site of a previous saphenectomy, not a typical burn wound.
Findings:
- The case highlights the development of Marjolin's ulcer in a non-burn chronic wound setting.
- Surgical intervention (excision and flap) was performed to manage the malignancy.
- The article discusses current treatment modalities for Marjolin's ulcer.
Implications:
- Timely treatment of chronic ulcerative lesions is paramount for preventing the development of Marjolin's ulcer.
- This case expands the known etiology of Marjolin's ulcer beyond common burn wounds.
- Further research into standardized treatment protocols for Marjolin's ulcer is warranted.
Related Concept Videos
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Peripheral Artery Disease V: Postoperative Nursing Management
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.

